Sort
21,281 grants matching “influenza”
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease
$1,424,781Richard C Boucher · Univ Of North Carolina Chapel Hill · UH2 · FY2015 · HL
Center for Research on Influenza Pathogenesis
$1,423,836Icahn School Of Medicine At Mount Sinai · N01 · FY2008 · AI
NHGRI Advanced Imaging & Analysis Core
$1,421,824Stephen Wincovitch · National Human Genome Research Institute · ZIC · FY2024 · HG
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,420,176Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanisms and Enviromental Determinants of Rhinovirus Illness Severity
$1,418,656James E. Gern · University Of Wisconsin-Madison · U19 · FY2015 · AI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases
$1,417,922Shawn Iadonato · Kineta, Inc. · N01 · FY2015 · AI
Drivers of individual variation in influenza vaccine response and protection from infection
$1,417,855Sarah Cobey · University Of Chicago · R01 · FY2024 · AI
Germline targeting influenza immunogens
$1,417,715David Nemazee · Scripps Research Institute, The · R01 · FY2017 · AI
Emerging Infections Program
$1,417,714Timothy F. Jones · Tennessee State Department Of Health · U01 · FY2011 · CI
Enhancing the antiviral memory B cell response
$1,417,500Brian Laidlaw · Washington University · DP2 · FY2021 · AI
A Phase 1/2a, randomized study of a Tfh-targeting genetic vaccine adjuvant designed to induce broad, durable immune responses
$1,417,453Kara W Chew · University Of California Los Angeles · U01 · FY2025 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$1,416,121John Jay Treanor · University Of Rochester · N01 · FY2018 · AI
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
$1,413,786Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2015 · IP
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research
$1,413,786Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2015 · IP
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UG3 · FY2017 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UG3 · FY2018 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UH3 · FY2021 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UH3 · FY2020 · HL
Lung-on-a-Chip Disease Models for Efficacy Testing
$1,413,750Donald E Ingber · Harvard University · UH3 · FY2019 · HL
SARS-CoV-2 correlates of protection in a Latino-origin population
$1,413,439Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2020 · CA
Pandemic influenza DNA vaccine Development
$1,413,407Lawrence R Smith · Vical, Inc. · U01 · FY2007 · AI
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,412,877John Christian Victor · Path · U01 · FY2009 · IP
Structure and dynamics of RNA elements regulating viral aberrant RNA synthesis
$1,412,295Arend Jan Te Velthuis · Princeton University · DP2 · FY2022 · AI
Structural Biology Of Virus Assembly
$1,411,722Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2012 · AR
Manipulating natural host immunoregulation via IDO during viral Infection
$1,410,329Andrew Lee Mellor · Augusta University · U01 · FY2013 · AI